BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10728960)

  • 1. Serum cholesterol level, cigarette smoking, and vasomotor responses to L-arginine in narrowed epicardial coronary arteries.
    Tentolouris C; Tousoulis D; Davies GJ; Stefanadis C; Toutouzas P
    Am J Cardiol; 2000 Feb; 85(4):500-3, A11. PubMed ID: 10728960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does passive smoking impair endothelium-dependent coronary artery dilation in women?
    Sumida H; Watanabe H; Kugiyama K; Ohgushi M; Matsumura T; Yasue H
    J Am Coll Cardiol; 1998 Mar; 31(4):811-5. PubMed ID: 9525552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function.
    Zeiher AM; Schächinger V; Minners J
    Circulation; 1995 Sep; 92(5):1094-100. PubMed ID: 7648652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced coronary vasodilation in patients with familial hypercholesterolemia following intracoronary injection of isosorbide dinitrate.
    Saku K; Jimi S; Sasaki N; Nii T; Shirai K; Koga N; Arakawa K
    Jpn Circ J; 1995 Dec; 59(12):808-14. PubMed ID: 8788372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary segmental responses to acetylcholine in patients with hypercholesterolemia.
    Kato M; Shiode N; Hiraoka A; Yamagata T; Matsuura H; Kajiyama G
    J Atheroscler Thromb; 1996; 3(1):39-44. PubMed ID: 9225238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers.
    Kugiyama K; Yasue H; Ohgushi M; Motoyama T; Kawano H; Inobe Y; Hirashima O; Sugiyama S
    J Am Coll Cardiol; 1996 Nov; 28(5):1161-7. PubMed ID: 8890810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of smoking on nitric oxide synthesis in epicardial normal and atheromatous coronary arteries.
    Tentolouris C; Tousoulis D; Davies G; Tsioufis C; Kallikazaros I; Michailidis A; Trikas A; Toutouzas P; Stefanadis C
    Int J Cardiol; 2004 May; 95(1):69-73. PubMed ID: 15159041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of nitric oxide synthesis in human epicardial coronary arteries and stenoses in relation to serum lipid level.
    Tentolouris C; Tousoulis D; Crake T; Katsimaglis G; Stefanadis C; Davies G; Toutouzas P
    Atherosclerosis; 1999 Dec; 147(2):285-91. PubMed ID: 10559514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients.
    Leung WH; Lau CP; Wong CK
    Lancet; 1993 Jun; 341(8859):1496-500. PubMed ID: 8099379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardization of coronary vasomotor tone with intracoronary nitroglycerin.
    Jost S; Sturm M; Hausmann D; Lippolt P; Lichtlen PR
    Am J Cardiol; 1996 Jul; 78(1):120-3. PubMed ID: 8712104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of smoking status on progression of endothelial dysfunction. TREND Investigators. Trial on Reversing Endothelial Dysfunction.
    Pepine CJ; Schlaifer JD; Mancini GB; Pitt B; O'Neill BJ; Haber HE
    Clin Cardiol; 1998 May; 21(5):331-4. PubMed ID: 9595215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse disorder of coronary artery vasomotility in patients with coronary spastic angina. Hyperreactivity to the constrictor effects of acetylcholine and the dilator effects of nitroglycerin.
    Okumura K; Yasue H; Matsuyama K; Ogawa H; Kugiyama K; Ishizaka H; Sumida H; Fujii H; Matsunaga T; Tsunoda R
    J Am Coll Cardiol; 1996 Jan; 27(1):45-52. PubMed ID: 8522709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired endothelium-dependent vasodilation of coronary resistance vessels in hypercholesterolemic patients.
    Shiode N; Kato M; Hiraoka A; Yamagata T; Matsuura H; Kajiyama G
    Intern Med; 1996 Feb; 35(2):89-93. PubMed ID: 8680111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient impairment of vasomotion function after successful chronic total occlusion recanalization.
    Galassi AR; Tomasello SD; Crea F; Costanzo L; Campisano MB; Marzá F; Tamburino C
    J Am Coll Cardiol; 2012 Feb; 59(8):711-8. PubMed ID: 22340262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking is associated with epicardial coronary endothelial dysfunction and elevated white blood cell count in patients with chest pain and early coronary artery disease.
    Lavi S; Prasad A; Yang EH; Mathew V; Simari RD; Rihal CS; Lerman LO; Lerman A
    Circulation; 2007 May; 115(20):2621-7. PubMed ID: 17485580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise-induced vasomotion of angiographically normal and stenotic coronary arteries improves after cholesterol-lowering drug therapy with bezafibrate.
    Seiler C; Suter TM; Hess OM
    J Am Coll Cardiol; 1995 Dec; 26(7):1615-22. PubMed ID: 7594094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary segmental responses to acetylcholine and bradykinin in patients with atherosclerotic risk factors.
    Kato M; Shiode N; Yamagata T; Matsuura H; Kajiyama G
    Am J Cardiol; 1997 Sep; 80(6):751-5. PubMed ID: 9315582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of exercise and cold pressor test on the vasomotor response of normal and atherosclerotic coronary arteries and their relation to the flow-mediated mechanism.
    Dubois-Randé JL; Dupouy P; Aptecar E; Bhatia A; Teiger E; Hittinger L; Berdeaux A; Castaigne A; Geschwind H
    Am J Cardiol; 1995 Sep; 76(7):467-73. PubMed ID: 7653446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Response of coronary arteries to intracoronary acetylcholine infusion in patients with familial hypercholesterolemia].
    Shimizu K; Shimizu M; Sugihara N; Kita Y; Yoshio H; Yamazaki T; Okeie K; Koizumi J; Mabuchi H; Takeda R
    J Cardiol; 1992; 22(2-3):439-46. PubMed ID: 1339802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasomotor Response to Nitroglycerine Over 5 Years Follow-Up After Everolimus-Eluting Bioresorbable Scaffold Implantation.
    Dudek D; Rzeszutko Ł; Onuma Y; Sotomi Y; Depukat R; Veldhof S; Ediebah D; Staehr P; Zasada W; Malinowski KP; Kaluza GL; Serruys PW
    JACC Cardiovasc Interv; 2017 Apr; 10(8):786-795. PubMed ID: 28427595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.